-+ 0.00%
-+ 0.00%
-+ 0.00%

Rani Therapeutics Hldgs Q4 2024 GAAP EPS $(0.27) Misses $(0.25) Estimate

Benzinga·03/31/2025 20:07:29
Listen to the news
Rani Therapeutics Hldgs (NASDAQ:RANI) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.25) by 8 percent. This is unchanged from the same period last year.